Blood Vessels News and Research

RSS

Implanted devices are giving cardiologists a new view of subtle changes in a key measurement of heart health

Implanted devices intended to optimize the cardiac function of patients with heart failure have provided new insights into which patients might be at higher risk of dying suddenly from their disease, according to researchers at Duke University Medical Center.

7 Mar 2005

Use of cilostazol, clopidogrel and aspirin results in a significant reduction of thrombotic complications in the prevention of heart attacks

Three drugs, each of which works in a different way, are used in anti-platelet therapy to help prevent restenosis (the reclogging of blood vessels after they have been cleared with percutaneous coronary intervention or PCI) or thrombosis (obstruction of an artery or vein by a blood clot).

7 Mar 2005

Stent trial fails to meet endpoints

Angiotech Pharmaceuticals has announced that results from the REALITY Trial, a head-to-head trial sponsored by Cordis Corporation, comparing the JNJ CYPHER® stent and the TAXUS® stent, were presented at the American College of Cardiology Annual Scientific Session. The trial failed to meet its primary endpoint.

7 Mar 2005

First genetic marker to help identify ruptured brain aneurysm

Mayo Clinic researchers have discovered a genetic marker that may pave the way for a fast, inexpensive blood test to predict one type of deadly stroke that strikes 30,000 people in the United States annually.

6 Mar 2005

Meditation may reduce heart disease risk

Black adolescents with high normal blood pressure who practice transcendental meditation improve the ability of their blood vessels to relax and may reduce their risk of becoming adults with cardiovascular disease, researchers say.

3 Mar 2005

Inflammation is a strong risk factor for cardiovascular disease among rheumatoid arthritis patients

Mayo Clinic epidemiologists have found that the systemic inflammation characterizing rheumatoid arthritis may be to blame for the increased risk of cardiovascular death in patients with the disease.

3 Mar 2005

Radiopharmaceuticals and lasers produce sound to treat and detect cancerous moles

When treating skin cancer, differentiating between melanoma and healthy moles can be difficult. Doctors must know the shape of the cancer and how deep it is before treating the problem. Now, a skin care specialist at the University of Missouri-Columbia has teamed with MU engineering and internal medicine professors to develop a better identification and treatment process.

1 Mar 2005

Growing evidence base supports focus on mind-body connection in heart disease

Cardiologists should recognize and help manage depression, stress and other common psychosocial risk factors that play a powerful role in the wellbeing and health outcomes of heart disease patients, according to an article(PDF) in the March 1, 2005 issue of the Journal of the American College of Cardiology.

1 Mar 2005

Celebrex provides a two pronged attack against prostate cancer

Celecoxib, a selective COX-2 inhibitor with promising anti-cancer properties, has now been found to attack prostate cancer cells in a second way that differs from Vioxx (rofecoxib), another anti-inflammatory drug that also inhibits COX-2.

1 Mar 2005

New cancer drug Avastin keeps cancer under control

Data published for the first time today in the leading Journal of Clinical Oncology showed that the unique new cancer drug Avastin keeps cancer under control for a significantly longer duration, even when used in a group of elderly patients with advanced colorectal cancer who are too sick to tolerate traditional aggressive chemotherapy.

1 Mar 2005

Mystery blood vessel disorder implicated in lacunar or "mini" strokes

Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.

28 Feb 2005

Genzyme begins gene transfer trial for peripheral arterial disease

Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.

24 Feb 2005

Common clinical problem, Rosacea

A number of clinical symptoms and signs are included under the broad group Rosacea. Facial flushing, the appearance of broken blood vessels and persistent redness of the face, eruption of inflamed spots & pimples, on the face and thickening of the sebaceous glands of the nose, with swelling & congestion in that area.

24 Feb 2005

Government grant pumps Vascam`s commercialisation

VasCam Pty Ltd has been awarded a Queensland Government Innovation Start-up Scheme (ISUS) grant which will help progress its technology to the clinical trial stage.

23 Feb 2005

Simple saliva test can predict whether children will get cavities

A simple saliva test can predict for the first time whether children will get cavities, how many cavities they will get and even which teeth are most vulnerable, USC researchers say.

23 Feb 2005

Researchers have identified a protein called HIF-2a, which is important in retina formation

Hoping to prevent blindness in premature babies, UT Southwestern Medical Center researchers have identified a protein that responds to oxygen levels in cells and tissues and also affects the developing eye.

22 Feb 2005

Computer imaging and web-based 3D tools help surgeons predict patient outcomes

People are as different on the inside as they are on the outside, making it difficult to predict how an individual will respond to a surgical intervention without resorting to statistics and educated guesses.

22 Feb 2005

Better ways to heal and regenerate bones using microcomputed tomography imaging

Tissue engineers can choose from a wide range of living cells, biomaterials and proteins to repair a bone defect. But finding the optimum combination requires improved methods for tracking the healing process.

20 Feb 2005

Nonsurgical microspheres an option for liver cancer patients

A study in February’s Journal of Vascular and Interventional Radiology found that patients undergoing liver cancer treatment with Theraspheres?, radioactive microspheres containing Yittrium-90, can tolerate a 150 Gy single dose or 268 Gy repeated dose without risk of radiation-induced liver disease.

17 Feb 2005

Olmesartan improves blood supply to kidneys

How do medications that block the renin-angiotensin system (RAS blockers) work to protect against kidney disease in people with diabetes? At least partly by improving the blood supply to the kidneys, suggests a study in the April Journal of the American Society of Nephrology.

17 Feb 2005